SEC Form 5 · accession 0001479791-19-000001
INVO Bioscience, Inc. · IVOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Claude Ranoux
10% Owner
Period of report
Dec 31, 2018
Accepted (ET)
Feb 1, 2019 · 5:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001417926
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| INVO BIOSCIENCE Common Stock | Jan 2, 2018 | S | 600 | $0.155 | D | 26,177,997 | D | |
| INVO BIOSCIENCE Common STOCK | Jan 2, 2018 | S | 100 | $0.15 | D | 26,177,897 | D | |
| INVO BIOSCIENCE Common Stock | Jan 4, 2018 | S | 2,134 | $0.146 | D | 26,175,763 | D | |
| INVO BIOSCIENCE Common Stock | Jan 5, 2018 | S | 500,000 | $0.05 | D | 25,675,763 | D | |
| INVO BIOSCIENCE Common Stock | Jan 5, 2018 | S | 50,000 | $0.12 | D | 26,625,763 | D | |
| INVO BIOSCIENCE Common Stock | Jan 5, 2018 | S | 20,000 | $0.125 | D | 25,605,763 | D | |
| INVO BIOSCIENCE Common Stock | Jan 8, 2018 | S | 30,000 | $0.144 | D | 25,575,763 | D | |
| INVO BIOSCIENCE Common Stock | Jan 11, 2018 | S | 5,100 | $0.15 | D | 25,570,663 | D | |
| INVO BIOSCIENCE Common Stock | Jan 12, 2018 | S | 7,445 | $0.145 | D | 25,562,218 | D | |
| INVO BIOSCIENCE Common Stock | Jan 16, 2018 | S | 600 | $0.145 | D | 25,562,618 | D | |
| INVO BIOSCIENCE Common Stock | Jan 19, 2018 | S | 3,000 | $0.125 | D | 25,559,618 | D | |
| INVO BIOSCIENCE Common Stock | Jan 22, 2018 | S | 10,000 | $0.116 | D | 25,549,618 | D | |
| INVO BIOSCIENCE Common Stock | Jan 22, 2018 | S | 20,000 | $0.117 | D | 25,529,618 | D | |
| INVO BIOSCIENCE Common Stock | Jan 22, 2018 | S | 13,500 | $0.1195 | D | 25,516,118 | D | |
| INVO BIOSCIENCE Common Stock | Jan 25, 2018 | S | 2,100 | $0.119 | D | 25,514,018 | D | |
| INVO BIOSCIENCE Common Stock | Jan 29, 2018 | S | 31,319 | $0.115 | D | 25,482,699 | D | |
| INVO BIOSCIENCE Common Stock | Jan 31, 2018 | S | 100 | $0.117 | D | 25,482,599 | D | |
| INVO BIOSCIENCE Common Stock | Feb 1, 2018 | S | 9,500 | $0.117 | D | 25,473,099 | D | |
| INVO BIOSCIENCE Common Stock | Feb 1, 2018 | S | 1,100 | $0.116 | D | 25,471,999 | D | |
| INVO BIOSCIENCE Common Stock | Feb 2, 2018 | S | 8,000 | $0.116 | D | 25,463,999 | D | |
| INVO BIOSCIENCE Common Stock | Feb 6, 2018 | S | 100 | $0.112 | D | 25,463,899 | D | |
| INVO BIOSCIENCE Common Stock | Feb 7, 2018 | S | 16,015 | $0.1115 | D | 25,447,884 | D | |
| INVO BIOSCIENCE Common Stock | Feb 9, 2018 | S | 1,000 | $0.1115 | D | 25,446,884 | D | |
| INVO BIOSCIENCE Common Stock | Feb 13, 2018 | S | 11,808 | $0.11 | D | 25,435,076 | D | |
| INVO BIOSCIENCE Common Stock | Feb 14, 2018 | S | 100 | $0.11 | D | 25,434,976 | D | |
| INVO BIOSCIENCE Common Stock | Feb 15, 2018 | S | 11,050 | $0.11 | D | 25,423,926 | D | |
| INVO BIOSCIENCE Common Stock | Feb 16, 2018 | S | 2,740 | $0.11 | D | 25,421,186 | D | |
| INVO BIOSCIENCE Common Stock | Feb 20, 2018 | S | 100 | $0.1114 | D | 25,421,086 | D | |
| INVO BIOSCIENCE Common Stock | Feb 20, 2018 | S | 23,260 | $0.11 | D | 25,397,826 | D | |
| INVO BIOSCIENCE Common Stock | Feb 20, 2018 | S | 25,000 | $1,080.00 | D | 25,372,826 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
The table of Form-5 reported the first thirty transactions of 2018. The eleven other transactions for year 2018 will be reported on another Form-5 which will follow.